Stock listing
Stockholm:ONCOZ OncoZenge AB Aktie
Home listing (Stockholm) of OncoZenge AB
Follow OncoZenge AB into a list and get an email when it puts out news.
Share price · OMXSTO:ONCOZ
3.11 SEK -0.00 (-0.2%)
Close on Nov 2, 2026
- Day range
- 2.89 – 3.35 SEKNov 2, 2026
- Volume
- 86,625 sharesNov 2, 2026
- Market cap
- 77.78M SEKAt the close on Nov 2, 2026 · price × 25.05M shares outstanding
- 52-week range
- 2.89 – 10.28 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- 217,596 SEKMedian day 40,065 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:ONCOZ · Home | 3.105 SEK | -0.005 (-0.2%) | 86,625 | 3.115 | 3.345 | 2.89 | 3.11 | Close on Nov 2, 2026 |
| Frankfurt:8LY | €0.259 EUR | -0.016 (-5.7%) | — | €0.259 | €0.259 | €0.259 | €0.274 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:ONCOZ · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 3.105 | -0.005 | -0.2% | 3.115 | 3.345 | 2.89 | 86,625 | |
| 3.11 | -0.08 | -2.5% | 3.18 | 3.18 | 3.04 | 22,382 | |
| 3.19 | +0.06 | +1.9% | 3.13 | 3.20 | 3.01 | 63,280 | |
| 3.13 | -0.03 | -0.9% | 3.215 | 3.215 | 3.09 | 47,020 | |
| 3.16 | -0.055 | -1.7% | 3.40 | 3.40 | 3.15 | 39,517 | |
| 3.215 | -0.035 | -1.1% | 3.16 | 3.35 | 3.16 | 81,022 | |
| 3.25 | -0.045 | -1.4% | 3.25 | 3.37 | 3.22 | 21,676 | |
| 3.295 | -0.055 | -1.6% | 3.215 | 3.35 | 3.215 | 22,901 | |
| 3.35 | +0.07 | +2.1% | 3.25 | 3.425 | 3.22 | 42,483 | |
| 3.28 | +0.03 | +0.9% | 3.28 | 3.28 | 3.16 | 53,452 | |
| 3.25 | -0.21 | -6.1% | 3.33 | 3.445 | 3.24 | 51,378 | |
| 3.46 | +0.21 | +6.5% | 3.29 | 3.485 | 3.245 | 52,705 | |
| 3.25 | -0.35 | -9.7% | 3.42 | 3.575 | 3.225 | 139,923 | |
| 3.60 | -0.05 | -1.4% | 3.65 | 3.735 | 3.50 | 31,188 | |
| 3.65 | -0.135 | -3.6% | 3.705 | 3.745 | 3.52 | 41,531 | |
| 3.785 | -0.395 | -9.4% | 4.485 | 4.485 | 3.505 | 129,923 | |
| 4.18 | +0.58 | +16.1% | 3.60 | 4.20 | 3.595 | 60,402 | |
| 3.60 | +0.285 | +8.6% | 3.315 | 3.78 | 3.205 | 70,350 | |
| 3.315 | +0.01 | +0.3% | 3.345 | 3.345 | 3.145 | 28,777 | |
| 3.305 | -0.015 | -0.5% | 3.255 | 3.35 | 3.20 | 28,843 | |
| 3.32 | -0.195 | -5.5% | 3.62 | 3.62 | 3.28 | 53,283 | |
| 3.515 | +0.065 | +1.9% | 3.545 | 3.785 | 3.39 | 108,323 | |
| 3.45 | 0.00 | 0.0% | 3.54 | 3.59 | 3.45 | 28,634 | |
| 3.45 | +0.24 | +7.5% | 3.29 | 3.665 | 3.29 | 140,900 | |
| 3.21 | -0.01 | -0.3% | 3.325 | 3.38 | 3.175 | 72,591 | |
| 3.22 | -0.16 | -4.7% | 3.36 | 3.40 | 3.22 | 28,511 | |
| 3.38 | -0.02 | -0.6% | 3.50 | 3.60 | 3.26 | 29,110 | |
| 3.40 | -0.10 | -2.9% | 3.50 | 3.67 | 3.40 | 17,258 | |
| 3.50 | +0.18 | +5.4% | 3.50 | 3.695 | 3.50 | 26,105 | |
| 3.32 | -0.075 | -2.2% | 3.20 | 3.595 | 3.20 | 84,888 | |
| 3.395 | -0.105 | -3.0% | 3.50 | 3.50 | 3.15 | 34,585 | |
| 3.50 | +0.175 | +5.3% | 3.30 | 3.845 | 3.30 | 33,652 | |
| 3.325 | -0.265 | -7.4% | 3.585 | 3.685 | 3.145 | 34,840 | |
| 3.59 | +0.395 | +12.4% | 3.125 | 3.90 | 3.115 | 48,684 | |
| 3.195 | -0.03 | -0.9% | 3.10 | 3.365 | 3.10 | 66,583 | |
| 3.225 | -0.175 | -5.1% | 3.30 | 3.44 | 3.13 | 37,900 | |
| 3.40 | -0.06 | -1.7% | 3.33 | 3.495 | 3.215 | 63,848 | |
| 3.46 | +0.06 | +1.8% | 3.40 | 3.495 | 3.335 | 21,300 | |
| 3.40 | -0.13 | -3.7% | 3.53 | 3.70 | 3.36 | 70,741 | |
| 3.53 | +0.03 | +0.9% | 3.45 | 3.69 | 3.45 | 49,541 | |
| 3.50 | -0.08 | -2.2% | 3.595 | 3.69 | 3.445 | 69,078 | |
| 3.58 | -0.24 | -6.3% | 3.78 | 3.91 | 3.41 | 201,365 | |
| 3.82 | -0.43 | -10.1% | 4.25 | 4.25 | 3.595 | 167,463 | |
| 4.25 | +0.25 | +6.3% | 3.98 | 4.25 | 3.80 | 32,066 | |
| 4.00 | -0.08 | -2.0% | 4.49 | 4.545 | 3.70 | 103,519 | |
| 4.08 | -0.175 | -4.1% | 4.264 | 4.456 | 3.963 | 78,138 | |
| 4.255 | -0.108 | -2.5% | 4.255 | 4.497 | 3.759 | 83,995 | |
| 4.364 | -0.642 | -12.8% | 4.672 | 4.923 | 4.272 | 98,976 | |
| 5.006 | -0.674 | -11.9% | 3.98 | 5.006 | 3.262 | 341,661 | |
| 5.68 | -0.15 | -2.6% | 5.90 | 5.90 | 5.52 | 10,093 | |
| 5.83 | -0.36 | -5.8% | 5.80 | 5.99 | 5.80 | 11,757 | |
| 6.19 | +0.34 | +5.8% | 5.75 | 6.20 | 5.62 | 28,912 | |
| 5.85 | -0.03 | -0.5% | 5.89 | 5.89 | 5.66 | 6,556 | |
| 5.88 | -0.12 | -2.0% | 5.99 | 5.99 | 5.75 | 4,390 | |
| 6.00 | +0.10 | +1.7% | 5.80 | 6.00 | 5.80 | 6,995 | |
| 5.90 | -0.15 | -2.5% | 6.05 | 6.39 | 5.80 | 33,702 | |
| 6.05 | -0.12 | -1.9% | 5.92 | 6.21 | 5.92 | 22,641 | |
| 6.17 | +0.15 | +2.5% | 5.89 | 6.48 | 5.89 | 22,273 | |
| 6.02 | -0.19 | -3.1% | 6.21 | 6.21 | 6.00 | 6,758 | |
| 6.21 | +0.46 | +8.0% | 5.76 | 6.21 | 5.76 | 37,491 | |
| 5.75 | -0.46 | -7.4% | 6.21 | 6.21 | 5.40 | 40,613 | |
| 6.21 | +0.02 | +0.3% | 6.07 | 6.23 | 5.97 | 25,010 | |
| 6.19 | -0.12 | -1.9% | 6.31 | 6.31 | 5.96 | 42,972 | |
| 6.31 | -0.03 | -0.5% | 6.56 | 6.56 | 6.30 | 8,333 | |
| 6.34 | -0.01 | -0.2% | 6.35 | 6.59 | 6.30 | 9,715 | |
| 6.35 | -0.22 | -3.3% | 6.73 | 6.74 | 6.35 | 16,708 |
- Ticker
- Stockholm:ONCOZ
- Asset type
- Stock
- Exchange
- Stockholm
- Currency
- SEK
What changed lately
Latest news release · Sep 23, 2026
OncoZenge: Rights issue concludes at ~92% subscription
Latest news
OncoZenge: Rights issue concludes at ~92% subscription
Sep 23, 2026
Closed 3.40 (-2.9%) on Sep 24, 2026
OncoZenge announces the final outcome of the rights issue
Sep 22, 2026
Closed 3.50 (+5.4%) on Sep 23, 2026
OncoZenge announces the preliminary outcome of the rights issue
Sep 18, 2026
Closed 3.40 (-3.0%) on Sep 21, 2026
OncoZenge: New patent application targets dental and oral pain
Sep 11, 2026
Closed 3.40 (-1.7%) on Sep 11, 2026
OncoZenge Files New Patent Application to Expand BupiZenge™ IP Protection into Dental and Oral Medical Use
Sep 11, 2026
Closed 3.40 (-1.7%) on Sep 11, 2026
OncoZenge AB advances global patent strategy for BupiZenge™ with filings in 17 markets
Aug 31, 2026
Closed 4.08 (-4.1%) on Aug 31, 2026
OncoZenge secures bridge financing of SEK 2.0 million ahead of rights issue
Aug 28, 2026
Closed 4.26 (-2.5%) on Aug 28, 2026
OncoZenge: SEK33.3m Rights issue announced
Aug 26, 2026
Closed 5.01 (-11.9%) on Aug 26, 2026
OncoZenge resolves on a rights issue of approximately SEK 33.3 million and publishes preliminary financial information for the second quarter of 2026
Aug 25, 2026
Closed 5.01 (-11.9%) on Aug 26, 2026
OncoZenge completes partial registration of shares in directed share issue
Aug 21, 2026
Closed 6.19 (+5.8%) on Aug 21, 2026
Financings
Rights offering of shares
Sep 22, 2026 · US$3.12M
Closed: SEK 30.7M raised · SEK 3 a share · Vator Securities AB +1
Dealers: Vator Securities AB, Stockholm Corporate Finance AB
Buyers: LINC AB (subscription commitment of SEK 2,633,865 (7.9%)); Andreas Adnan Özbek (subscription commitment of SEK 1,423,125 (4.3%)); Stian Kildal (CEO; subscription commitment of SEK 1,125,000 (3.4%), privately and through companies); Paul Murtagh through Fenix Dental AB (subscription commitment of SEK 270,000 (0.8%)); M Owens Management Consulting AB (subscription commitment of SEK 22,500 (0.07%)); Life Science Invest Fund (stands behind the guarantee through put option agreements with the guarantor)
Insiders: Board members, senior management and certain larger shareholders committed to subscribe approximately SEK 5.5 million, about 16.4 percent of the Rights Issue
Use of proceeds: Complete the Phase III BupiZenge trial and extend runway (65%), MAA preparations (25%), general corporate purposes, business development and IP (10%)
Announced Aug 25, 2026 · Update Sep 18, 2026 · Closed Sep 22, 2026
Bridge loan
Aug 28, 2026 · US$208,669
Closed: SEK 2M raised
Buyers: John Haurum (bridge loan of SEK 2.0 million, which he may request be set off against new shares at the Rights Issue subscription price)
Use of proceeds: To secure the Company's liquidity requirements until the approximately SEK 33.3 million rights issue is completed
Private placement of shares
Aug 21, 2026 · US$528,343
Tranche closed: SEK 5M raised · SEK 6.47 a share
Buyers: Sichuan Yangtian Bio-Pharmaceutical Co., Ltd (directed share issue of approximately SEK 15.1 million; partial payment of SEK 5.0 million made); Sichuan Yangtian Bio-Pharmaceutical Co, Ltd (remaining subscription proceeds of approximately SEK 10.1 million to be paid)
Update Jul 10, 2026 · Update Aug 14, 2026 · Tranche closed Aug 21, 2026
OncoZenge AB on 6ix
- News releases
- 33 in the last 12 months · 34 in all · newest Sep 23, 2026 · oldest 2025
Where OncoZenge AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:ONCOZ · Home listing · This page | Stockholm | Sweden | SEK |
| Frankfurt:8LY | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about OncoZenge AB.